Subsidiary of Tasly Pharmaceutical Group (600535.SU) obtained the registration certificate for the pharmaceutical of Dapoxetine Hydrochloride Tablets.

Tasly Pharmaceutical Group (600535.SH) recently announced that its wholly-owned subsidiary, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.("Jiangsu Diyi"), has received the Drug Registration Certificate for Dapoxetine Hydrochloride Tablets issued by the National Medical Products Administration. It is reported that dapoxetine hydrochloride is a selective serotonin reuptake inhibitor that can bind and block serotonin reuptake receptors on presynaptic membranes, increase the concentration of serotonin in synapses, and achieve the effect of delaying ejaculation. Dapoxetine hydrochloride tablets are suitable for the treatment of premature ejaculation (PE) in males aged 18 to 64 and have a fast absorption.

Zhitong FinanceJul 8 03:37 ET

Tasly Pharmaceutical Group (SHSE:600535) Shareholders Have Endured a 17% Loss From Investing in the Stock Five Years Ago

The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results between individual stocks. So we wouldn't blame long term Tasly Pharmaceutical G

Simply Wall StJul 4 18:11 ET

Tasly Pharmaceutical Group's Allergy Tablet Passes Drug Quality, Efficacy Evaluation

Tasly Pharmaceutical Group (SHA:600535) unit Jiangsu Tasly Diyi Pharmaceutical's ketotifen fumarate tablets passed the generic drug quality and efficacy consistency evaluation of the State Drug Admini

MT NewswiresJun 20 00:29 ET

Tasly Pharmaceutical Group (600535.SH): has no equity relationship with Guotai Liquor

On June 19, Gelunhui reported that Tasly Pharmaceutical Group (600535.SH) stated on the investor communication platform that the listed company has no equity relationship with Guotai Liquor.

Gelonghui FinanceJun 19 04:43 ET

Tasly Pharmaceutical Group (600535.SH): The main raw materials Danshen and Sanqi can ensure large-scale and sustained supply.

On June 19th, Gelonhui reported that Tasly Pharmaceutical Group (600535.SH) stated on its investor interaction platform that the main active pharmaceutical ingredients of the company's main products, Danshen and Sanqi, are all purchased through its subsidiaries Shaanxi Shangluo and Yunnan Sanqi. The quality of raw materials is tracked and controlled to ensure large-scale and continuous supply.

Gelonghui FinanceJun 19 04:39 ET

Tasly Pharmaceutical Group (600535.SH) subsidiary pharmaceutical oxcarbazepine tablets passed the consistency evaluation of generic drugs.

Tasly Pharmaceutical Group (600535.SH) announced that its wholly-owned subsidiary, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., ...

Zhitong FinanceJun 19 03:33 ET